Search dm+d | This AMP cannot be matched against our prescribing data.
| Description | COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) 0.5ml dose suspension for injection multidose vials (Janssen-Cilag Ltd) |
| BNF code | 1404000ATBCAAAB |
| Virtual Medicinal Product | Generic COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) 0.5ml dose suspension for injection multidose vials |
| Name | COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) 0.5ml dose suspension for injection multidose vials |
| Abbreviated name | COVID-19 Vaccine Janssen 0.5ml inj multidose vials |
| Date of name applicability | 1 Sep 2021 |
| Previous name | COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) 0.5ml dose solution for injection multidose vials |
| Supplier | Janssen-Cilag Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| Previous licensing authority | None |
| Reason for change of licensing authority | Licence Granted |
| Date of change of licensing authority | 24 Nov 2021 |
| EMA additional monitoring | ✓ |
| Parallel import | ✗ |
| Restrictions on availability | Restricted Availability |
| Licensed Route | |
|---|---|
| Licenced route | Intramuscular |
| Actual Medicinal Product Packs | |
| COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) 0.5ml dose suspension for injection multidose vials (Janssen-Cilag Ltd) 50 dose 10 x 5 dose vials | |
| COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) 0.5ml dose suspension for injection multidose vials (Janssen-Cilag Ltd) 5 dose | |
dm+d data retrieved from TRUD: release NHSBSA_9.3.0_20240923000001, imported on 23rd September 2024 at 04:57:49.